Your search returned 2 results.

Results
	1.	Safety of adalimumab biosimilar MSB11022 (acetate-buffered formulation) in patients with moderately-to-severely active rheumatoid arthritis. [electronic resource] by Edwards, Christopher J Monnet, Joëlle Ullmann, Martin Vlachos, Pantelis Chyrok, Veranika Ghori, Vishal Producer: 20200406 In: Clinical rheumatology vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira(®) in healthy subjects. [electronic resource] by Hyland, Elizabeth Mant, Tim Vlachos, Pantelis Attkins, Neil Ullmann, Martin Roy, Sanjeev Wagner, Volker Producer: 20180108 In: British journal of clinical pharmacology vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search